Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 98

1.

The role of lipolysis stimulated lipoprotein receptor in breast cancer and directing breast cancer cell behavior.

Reaves DK, Fagan-Solis KD, Dunphy K, Oliver SD, Scott DW, Fleming JM.

PLoS One. 2014 Mar 17;9(3):e91747. doi: 10.1371/journal.pone.0091747. eCollection 2014.

PMID:
24637461
[PubMed - in process]
Free PMC Article
2.

Challenging the roles of CD44 and lipolysis stimulated lipoprotein receptor in conveying Clostridium perfringens iota toxin cytotoxicity in breast cancer.

Fagan-Solis KD, Reaves DK, Rangel MC, Popoff MR, Stiles BG, Fleming JM.

Mol Cancer. 2014 Jul 2;13:163. doi: 10.1186/1476-4598-13-163.

PMID:
24990559
[PubMed - in process]
Free PMC Article
3.

Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer.

Prat A, Parker JS, Karginova O, Fan C, Livasy C, Herschkowitz JI, He X, Perou CM.

Breast Cancer Res. 2010;12(5):R68. doi: 10.1186/bcr2635. Epub 2010 Sep 2.

PMID:
20813035
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Claudin-20 promotes an aggressive phenotype in human breast cancer cells.

Martin TA, Lane J, Ozupek H, Jiang WG.

Tissue Barriers. 2013 Jul 1;1(3):e26518. doi: 10.4161/tisb.26518. Epub 2013 Sep 20.

PMID:
24665404
[PubMed]
Free PMC Article
5.

Claudin expression in high-grade invasive ductal carcinoma of the breast: correlation with the molecular subtype.

Lu S, Singh K, Mangray S, Tavares R, Noble L, Resnick MB, Yakirevich E.

Mod Pathol. 2013 Apr;26(4):485-95. doi: 10.1038/modpathol.2012.187. Epub 2012 Dec 7.

PMID:
23222490
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Functional heterogeneity within the CD44 high human breast cancer stem cell-like compartment reveals a gene signature predictive of distant metastasis.

Leth-Larsen R, Terp MG, Christensen AG, Elias D, Kühlwein T, Jensen ON, Petersen OW, Ditzel HJ.

Mol Med. 2012 Sep 25;18:1109-21. doi: 10.2119/molmed.2012.00091.

PMID:
22692575
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Claudin-16 reduces the aggressive behavior of human breast cancer cells.

Martin TA, Harrison GM, Watkins G, Jiang WG.

J Cell Biochem. 2008 Sep 1;105(1):41-52. doi: 10.1002/jcb.21797.

PMID:
18442037
[PubMed - indexed for MEDLINE]
8.

DEC1 is positively associated with the malignant phenotype of invasive breast cancers and negatively correlated with the expression of claudin-1.

Liu Y, Miao Y, Wang J, Lin X, Wang L, Xu HT, Wang EH.

Int J Mol Med. 2013 Apr;31(4):855-60. doi: 10.3892/ijmm.2013.1279. Epub 2013 Feb 19.

PMID:
23426649
[PubMed - indexed for MEDLINE]
9.

Immunohistochemical features of claudin-low intrinsic subtype in metaplastic breast carcinomas.

Gerhard R, Ricardo S, Albergaria A, Gomes M, Silva AR, Logullo ÂF, Cameselle-Teijeiro JF, Paredes J, Schmitt F.

Breast. 2012 Jun;21(3):354-60. doi: 10.1016/j.breast.2012.03.001. Epub 2012 Mar 30.

PMID:
22464177
[PubMed - indexed for MEDLINE]
10.

Dysregulation of the epigenome in triple-negative breast cancers: basal-like and claudin-low breast cancers express aberrant DNA hypermethylation.

Roll JD, Rivenbark AG, Sandhu R, Parker JS, Jones WD, Carey LA, Livasy CA, Coleman WB.

Exp Mol Pathol. 2013 Dec;95(3):276-87. doi: 10.1016/j.yexmp.2013.09.001. Epub 2013 Sep 14.

PMID:
24045095
[PubMed - indexed for MEDLINE]
11.

Claudin 1 expression in basal-like breast cancer is related to patient age.

Blanchard AA, Ma X, Dueck KJ, Penner C, Cooper SC, Mulhall D, Murphy LC, Leygue E, Myal Y.

BMC Cancer. 2013 May 30;13:268. doi: 10.1186/1471-2407-13-268.

PMID:
23721519
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Expression and function of tight junction associated molecules in human breast tumor cells is not affected by the Ras-MEK1 pathway.

Macek R, Swisshelm K, Kubbies M.

Cell Mol Biol (Noisy-le-grand). 2003 Feb;49(1):1-11.

PMID:
12839332
[PubMed - indexed for MEDLINE]
13.

Dietary energy balance modulates epithelial-to-mesenchymal transition and tumor progression in murine claudin-low and basal-like mammary tumor models.

Dunlap SM, Chiao LJ, Nogueira L, Usary J, Perou CM, Varticovski L, Hursting SD.

Cancer Prev Res (Phila). 2012 Jul;5(7):930-42. doi: 10.1158/1940-6207.CAPR-12-0034. Epub 2012 May 15.

PMID:
22588949
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Numb protein expression correlates with a basal-like phenotype and cancer stem cell markers in primary breast cancer.

Rennstam K, McMichael N, Berglund P, Honeth G, Hegardt C, Rydén L, Luts L, Bendahl PO, Hedenfalk I.

Breast Cancer Res Treat. 2010 Jul;122(2):315-24. doi: 10.1007/s10549-009-0568-x. Epub 2009 Oct 1.

PMID:
19795205
[PubMed - indexed for MEDLINE]
15.

Autocrine CSF1R signaling mediates switching between invasion and proliferation downstream of TGFβ in claudin-low breast tumor cells.

Patsialou A, Wang Y, Pignatelli J, Chen X, Entenberg D, Oktay M, Condeelis JS.

Oncogene. 2014 Aug 4. doi: 10.1038/onc.2014.226. [Epub ahead of print]

PMID:
25088194
[PubMed - as supplied by publisher]
16.

Targeting Met and Notch in the Lfng-deficient, Met-amplified triple-negative breast cancer.

Zhang S, Chung WC, Miele L, Xu K.

Cancer Biol Ther. 2014 May;15(5):633-42. doi: 10.4161/cbt.28180. Epub 2014 Feb 20.

PMID:
24556651
[PubMed - in process]
17.

Comparative oncogenomics identifies breast tumors enriched in functional tumor-initiating cells.

Herschkowitz JI, Zhao W, Zhang M, Usary J, Murrow G, Edwards D, Knezevic J, Greene SB, Darr D, Troester MA, Hilsenbeck SG, Medina D, Perou CM, Rosen JM.

Proc Natl Acad Sci U S A. 2012 Feb 21;109(8):2778-83. doi: 10.1073/pnas.1018862108. Epub 2011 Jun 1.

PMID:
21633010
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

JMJD6 is a driver of cellular proliferation and motility and a marker of poor prognosis in breast cancer.

Lee YF, Miller LD, Chan XB, Black MA, Pang B, Ong CW, Salto-Tellez M, Liu ET, Desai KV.

Breast Cancer Res. 2012 May 23;14(3):R85.

PMID:
22621393
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

The expression patterns and correlations of claudin-6, methy-CpG binding protein 2, DNA methyltransferase 1, histone deacetylase 1, acetyl-histone H3 and acetyl-histone H4 and their clinicopathological significance in breast invasive ductal carcinomas.

Xu X, Jin H, Liu Y, Liu L, Wu Q, Guo Y, Yu L, Liu Z, Zhang T, Zhang X, Dong X, Quan C.

Diagn Pathol. 2012 Mar 29;7:33. doi: 10.1186/1746-1596-7-33.

PMID:
22455563
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Low-density lipoprotein receptor-related protein 1 is associated with proliferation and invasiveness in Her-2/neu and triple-negative breast carcinomas.

Catasus L, Gallardo A, Llorente-Cortes V, Escuin D, Muñoz J, Tibau A, Peiro G, Barnadas A, Lerma E.

Hum Pathol. 2011 Nov;42(11):1581-8. doi: 10.1016/j.humpath.2011.01.011. Epub 2011 Apr 14.

PMID:
21496869
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk